The Power of Innovation | Genetron Health Awarded "China Innovative Enterprise" Award by Financial Times

Release time:2019-11-12

On November 12th, the Financial Times Chinese Annual Forum 2019 themed 'Present & Prospects' was held in Hangzhou. The Forum also released the list of the FT Chinese China Innovative Enterprise 2019. Genetron Health is proud to be the only life sciences company awarded.

The Forum brought together 12 experts, scholars, entrepreneurs and executives from economics, finance, communications, medical, education background to deliver keynote speeches, attracted more than 350 representatives from government agencies, business communities, chambers of commerce, academic world, research institutions and media to discuss cross-disciplinary exploration and practice. Ten years ago, FTChinese Annual Forum was themed “2020: A New Era of China and the World”, and today China has apparently become a powerhouse in technological innovation for the world.

In the past decade, scientific and technological innovations have spawned new industries that promote human development, and also brought up a number of innovative enterprises that disrupted traditions. The Financial Times and, as international media with global vision, established the Financial Times China Innovative Enterprise Club last year to gather companies with new technologies, new ideas to facilitate new economies to jointly explore opportunities from economic change.

The Power of Innovation | Genetron Health Awarded

After a one-year research, the Financial Times and granted six “China Innovative Enterprise” awards, with Genetron Health being the “Leader in Cancer Precision Medicine”. Other award winners, including Digital Domain, and United Family Healthcare, Squirrel AI Learning, etc. are all leaders in respective fields. Excellent companies such as Luckin Coffee, UCAR, and Neo Capital was on the 2018 list.

Genetron Health has always regarded research and development as the engine of enterprise development. Adhering to the Principle of “Exploration, Application and Change”, and applying advanced molecular technologies and cutting-edge discoveries to the diagnosis and treatment of cancer, Genetron Health is committed to the full cycle management ranging from discovery, treatment, to prognosis. At present, Genetron Health has helped tens of thousands of doctors and cancer patients with personalized diagnosis and treatment, and partnered with internationally renowned pharmaceutical companies to develop targeted therapy and immunotherapy programs. Genetron Health is also committed to prevention and early intervention of cancer while it is curable. In the future, Genetron Health will further improve the full-cycle management of tumor to reach the goal that cancer is no longer fatal.


Http:// is the only Chinese business & finance website of the Financial Times Group, , which aims to provide Chinese business elites and policy makers with daily financial news, insights and news comments. Supported by the rich information sources of the Financial Times in the world, analyzes the major events that impact on the Chinese and global economy, becomes a 'must read' website with a truly international perspective for senior Chinese executive. currently has more than 2.9 million registered users, and available on mobile platforms including iOS, Android and Windows. In April 2018, launched paid subscription service to provide subscribers with customized information and services.

About the Financial Times

The Financial Times is one of the world’s leading news organizations, recognized internationally for its authority, integrity and accuracy. The Financial Times celebrated its 130th anniversary in 2018. It has a record of more than 940,000 paid subscribers, about three-quarters of whom are electronic subscribers.

Genetron Health Genetron Health Management
  • *To
  • *Subject
  • *Name
  • *Tel
  • Work Unit
  • *Email
  • 详细说明:
  • Verification code:
Genetron Health Genetron Health Management